Subject: New, Inc. President to Generate Significant New Revenue Streams for the Company

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
New, Inc. President to Generate Significant New Revenue Streams for the Company
Hot Stock to WatchHot Stock to Watch

Company: (OTCQB: CIIX)


Price: 0.945

Change (%): + 0.018 (1.94)

Volume: 5,271
CIIX Chart, Inc. Appoints Keevin Gillespie as the President of its Wholly-owned Subsidiary,, Inc.

SAN GABRIEL, California, August 7, 2017 /PRNewswire/ -, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announces that it has appointed Keevin Gillespie acting President of its wholly-owned subsidiary,, Inc., effective immediately. Mr. Gillespie will report directly to CIIX CEO, Warren Wang, and will be responsible for overseeing new business development, marketing and company operations throughout the North American market. Mr. Gillespie’s initial focus will be on promotion and branding of the Company’s newly launched health product line, ‘OptHemp’, which will be marketed through multiple sales channels, including online sales, retail sales, and third party distribution relationships with other health product retailers including acupuncturists, spas, chiropractic centers, etc. Mr. Gillespie is also spearheading the development of the Company’s network marketing division which is in early stage development.

“I’m honored to serve as the President of, Inc.,” says Mr. Gillespie. “As the many potential health benefits of hemp continue to be revealed through scientific research and development, I believe the Chinese community will embrace this rediscovered ancient remedy. I look forward to creating brand awareness and exposure for the Company’s ‘OptHemp’ product line, developing the Company’s network marketing division and generating significant new revenue streams for the Company in the coming year.”

Through Mr. Wang’s continued leadership as CEO of CIIX, Mr. Gillespie’s leadership as the President of, Inc., and Summer Yun’s leadership as the recently appointed CEO of CBD Biotechnology Co., Ltd, the Company hopes to ensure that its core financial services/media division and its newly developed direct-to-consumer division achieve their individual growth objectives set out for the coming year. will continue to focus on the development of its live video platform focusing on analysis of US stock markets, while and CBD Biotechnology Co. Ltd. will focus on direct-to-consumer sales of non-industrial hemp health and cosmetic products and other health-related products in the US and China.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks